I should have gone to cash when you posted this warning over a year ago, a piece of evidence of about hedge fund strategies. I would be back and be owning ten times my share count.

If you reflect, their strategy was brilliant.

Short the XBI in its entirety. Many of these firms are burning through cash to keep people on board. The FDA will be AWOL. There will be no trial progress to be concerned about for the health of your short. The FDA minions are working from home at snail pace, quitting in depressed conditions, they even refuse to travel and they can only support COVID therapies coming out of the woodwork with pre-clinical data.

Alaunos was a five dollar stock in February, 2021 and a one billion in market cap. Yet, there was not a single trial in progress and we knew it, and nothing was on the near-term.

Now it is a $100 million MC. You'd think we would at least be at $5 plus some measure to allow that we are now progressing in our trial. Patience. Take solace that the only "ALL-metastatic-cancers" trial that is open (? & recruiting?) at the NCI and it is using Sleeping Beauty in TCR-T.

(Don't be fooled by blogs that say other firms are engaged with the NCI in viral cancers or germline cancers are also metastatic cancers --- those are not metastatic and are rare in incidence). All the best.